HC
NEO icon

Henshaw Capital’s NeoGenomics NEO Stock Holding History

Henshaw Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,681
Closed -$229K – 230
2025
Q3 		$229K Sell
29,681
-10,549
-26% -$73.9K 0.01% 249
2025
Q2 		$294K Hold
40,230
– – 0.01% 278
2025
Q1 		$382K Buy
40,230
+10,317
+34% +$129K 0.02% 258
2024
Q4 		$493K Hold
29,913
– – 0.02% 224
2024
Q3 		$441K Buy
29,913
+7,411
+33% +$116K 0.02% 236
2024
Q2 		$312K Buy
22,502
+373
+2% +$5.29K 0.01% 239
2024
Q1 		$348K Hold
22,129
– – 0.02% 226
2023
Q4 		$358K Hold
22,129
– – 0.02% 212
2023
Q3 		$272K Buy
22,129
+11,102
+101% +$165K 0.02% 235
2023
Q2 		$177K Buy
+11,027
New +$182K 0.01% 252
2021
Q4 		– Sell
-5,812
Closed -$280K – 339
2021
Q3 		$280K Buy
+5,812
New +$269K 0.02% 273

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Henshaw Capital's NEO Position: Q4 2025 in Review

Henshaw Capital sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 29,681 shares — an estimated $229K sold.

Henshaw Capital first reported a position in NEO in Q3 2021 and held it in 11 quarters. The position peaked at $493K in Q4 2024. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Henshaw Capital reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Henshaw Capital sold 29,681 NeoGenomics shares in Q4 2025, an estimated $229K.
  • Henshaw Capital first reported a position in NeoGenomics in Q3 2021 and held it in 11 quarters.
  • Henshaw Capital's NeoGenomics position peaked at $493K in Q4 2024.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Henshaw Capital's 13F filing for Q4 2025, filed 28 May 2026.